Advancing Care in Vulvar Dermatoses: When and How to Use Systemic Agents
At the 2025 ODAC Dermatology Conference, Christina Kraus, MD, expanded on her earlier discussion of off-label topical approaches by surveying the landscape of systemic therapies for these challenging cases. Her lecture synthesized the latest evidence, highlighted patient-selection considerations, and introduced both established and emerging systemic agents—equippi …
At the 2025 ODAC Dermatology Conference, Christina Kraus, MD, expanded on her earlier discussion of off-label topical approaches by surveying the landscape of systemic therapies for these challenging cases. Her lecture synthesized the latest evidence, highlighted patient-selection considerations, and introduced both established and emerging systemic agents—equippi … Continue reading "Advancing Care in Vulvar Dermatoses: When and How to Use Systemic Agents"
ODAC Co-Chair Dr. Adam Friedman says some nuanced changes in recently published scientific literature have changed the way he approaches rosacea. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Friedman, who addressed the latest understanding of rosacea triggers. Should your still tell your rosacea patients to avoid coffee? Find out what the latest researc … 
When conducting surgical reconstruction, it’s important to think outside the box. That’s according to consulting dermatologist Dr. Timothy C. Flynn. Next Steps in Derm, in partnership with the ODAC Dermatology Conference interviewed Dr. Flynn, who shared questions dermatologists should ask when addressing a wound. Find out why considering shadows and highlights is important for positive outcom … 
A paradigm shift in the understanding of melasma is changing the way dermatology clinicians approach the condition. Next Steps in Derm, in partnership with the ODAC Dermatology Conference, interviewed Dr. Mukta Sachdev, head of the department of dermatology at Manipal Hospital, Bangalore, India. Watch as Dr. Sachdev shares why photoprotection, barrier function, and pollution are some of the factor … 
New developments in neurotoxins may lead to additional applications and improved safety, according to Dr. Terrence Keaney, associate clinical professor of dermatology at GW School of Medicine & Health Sciences. Next Steps in Derm, in partnership with ODAC Dermatology Conference, interviewed Dr. Keaney, who shared how a new botulinum toxin subtype may serve as a “tester toxin” for curious, …